Financial health
- The company is unprofitable; at its current free-cash-flow burn it has roughly 2.9 years of cash runway.
6 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $3M | -$242M | 0.0% | -1210.6% | 128.9% | -245.1% | -$30M | — | $89M |
| 2024 | $11M | -$64M | 0.0% | -239.7% | 297.3% | -131.1% | -$18M | — | $35M |
| 2023 | $0 | -$43M | — | — | -113.5% | -93.4% | -$41M | — | $36M |
| 2022 | — | -$36M | — | — | -47.4% | -40.3% | -$45M | — | $25M |
| 2021 | — | -$55M | — | — | -49.8% | -39.8% | -$50M | — | $33M |
| 2020 | — | -$33M | — | — | -69.2% | -52.7% | -$30M | — | $35M |
| Quarter | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Jun '26 | $5M | $50M | 0.0% | -207.4% | -22.9% | 43.4% | -$7M | — | $102M |
| Mar '26 | $5M | -$128M | 0.0% | -209.1% | 45.8% | -105.6% | -$13M | — | $107M |
| Dec '25 | $528000 | -$183M | 0.0% | -2393.8% | 97.5% | -185.5% | -$6M | — | $89M |
| Sep '25 | $983000 | -$72M | 0.0% | -1107.3% | 304.7% | -76.2% | -$9M | — | $81M |
| Jun '25 | $983000 | $40M | 0.0% | -917.3% | 84.4% | 38.7% | -$6M | — | $90M |
| Mar '25 | $983000 | -$27M | 0.0% | -971.6% | -475.3% | -23.5% | -$9M | — | $102M |
| Dec '24 | $655000 | -$28M | 0.0% | -1311.8% | 131.1% | -57.9% | $3M | — | $35M |
| Sep '24 | $10M | -$1M | 0.0% | 12.3% | -25.3% | -3.0% | -$7M | — | $31M |
| Jun '24 | — | -$25M | — | — | -416.7% | -56.0% | -$6M | — | $38M |
| Mar '24 | — | -$9M | — | — | -29.3% | -24.0% | -$9M | — | $27M |
| Dec '23 | — | -$9M | — | — | -23.5% | -19.3% | -$7M | — | $36M |
| Sep '23 | — | -$10M | — | — | -22.9% | -19.4% | -$10M | — | $34M |
| Jun '23 | — | -$9M | — | — | -17.0% | -14.7% | -$9M | — | $36M |
| Mar '23 | — | -$14M | — | — | -22.7% | -19.3% | -$14M | — | $28M |
| Dec '22 | — | -$775000 | — | — | -1.0% | -0.9% | -$353000 | — | $25M |
| Sep '22 | — | -$13M | — | — | -17.2% | -14.6% | -$14M | — | $26M |
| Jun '22 | — | -$14M | — | — | -15.5% | -13.4% | -$11M | — | $17M |
| Mar '22 | — | -$8M | — | — | -7.7% | -6.8% | -$19M | — | $14M |
| Dec '21 | — | -$15M | — | — | -13.6% | -10.9% | -$12M | — | $33M |
| Sep '21 | — | -$14M | — | — | -11.3% | -9.3% | -$15M | — | $61M |
How the market has priced SRZN against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
See the revenue and net-income charts above for Surrozen, Inc./DE's multi-year trend.
As of FY2025, Surrozen, Inc./DE reported — of total debt against $89M of cash.
In FY2025, gross margin was —, operating margin -1210.6%, and net margin -6960.8%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.